Kobayashi Pharmaceutical Co., Ltd. (4967.T)

Home
4967.T
Financials

5268 (JPY) • At close May 30, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue Numbers are in millions	165,600	173,455	166,258	155,252	150,514	168,052	167,479	156,761	160,067.6	137,211	128,344	127,293	121,532	131,166	130,528	129,082	125,544	228,133	257,502	247,335	216,052
Cost of Revenue Numbers are in millions	77,997	77,079	73,927	66,478	65,248	64,705	64,359	61,238	66,234.501	57,518	54,718	54,193	51,732	54,635	55,889	57,193	56,864	146,945	172,783	167,721	144,256
Gross Profit Numbers are in millions	87,603	96,376	92,331	88,774	85,266	103,347	103,120	95,523	93,833.099	79,693	73,626	73,100	69,800	76,531	74,639	71,889	68,680	81,188	84,719	79,614	71,796
Gross Profit Ratio Numbers are in millions	0.529	0.556	0.555	0.572	0.566	0.615	0.616	0.609	0.586	0.581	0.574	0.574	0.574	0.583	0.572	0.557	0.547	0.356	0.329	0.322	0.332
Reseach & Development Expenses Numbers are in millions	9,109	9,004	8,327	7,522	7,338	7,110	7,031	7,239	5,494.653	5,788	5,289	4,930	4,544	4,385	4,069	3,962	3,361	2,813	2,476	2,377	2,115
General & Administrative Expenses Numbers are in millions	31,322	29,869	5,024	5,200	5,141	5,492	5,706	5,504	3,630.838	4,800	4,696	4,728	4,813	9,817	9,913	9,960	9,697	14,996	4,612	4,011	3,572
Selling & Marketing Expenses Numbers are in millions	16,869	27,742	26,584	26,590	26,009	42,271	42,025	39,338	61,005	31,276	26,722	26,521	25,650	22,200	20,480	20,315	19,919	19,333	18,848	17,659	16,209
SG&A Numbers are in millions	48,191	57,611	31,608	31,790	31,150	47,763	47,731	44,842	64,635.838	36,076	31,418	31,249	30,463	32,017	30,393	30,275	29,616	34,329	23,460	21,670	19,781
Other Expenses Numbers are in millions	5,443	3,981	25,722	23,390	20,828	22,112	22,061	976	-603.998	-86	404	515	415	250	158	40	-226	-3,020	-3,219	-2,175	-1,999
Operating Expenses Numbers are in millions	62,743	70,596	65,657	62,702	59,316	76,985	76,823	72,589	70,734.49	61,427	55,703	54,971	52,889	50,340	49,498	48,163	46,292	54,491	45,604	43,485	39,381
Operating Income Numbers are in millions	24,860	25,780	26,669	26,065	25,943	26,355	26,289	22,925	23,098.609	18,260	17,917	18,122	16,903	27,026	25,552	23,750	21,882	23,353	36,166	16,879	30,960
Operating Income Ratio Numbers are in millions	0.15	0.149	0.16	0.168	0.172	0.157	0.157	0.146	0.144	0.133	0.14	0.142	0.139	0.206	0.196	0.184	0.174	0.102	0.14	0.068	0.143
Total Other Income Expenses Net Numbers are in millions	-10,946	1,779	1,281	1,571	692	449	-985	-353	3,305.325	495	2,139	1,544	1,950	524	-11,964	-9,173	-6,118	-10,897	-23,077	-2,870	-19,646
Income Before Tax Numbers are in millions	13,914	27,559	27,950	27,636	26,635	26,804	25,304	22,572	26,402.601	18,755	20,056	19,666	18,853	19,822	13,178	14,553	16,270	15,800	16,038	14,009	12,769
Income Before Tax Ratio Numbers are in millions	0.084	0.159	0.168	0.178	0.177	0.159	0.151	0.144	0.165	0.137	0.156	0.154	0.155	0.151	0.101	0.113	0.13	0.069	0.062	0.057	0.059
Income Tax Expense Numbers are in millions	3,842	7,221	7,927	7,920	7,430	7,665	7,280	6,709	7,391.982	5,300	7,608	7,360	6,676	8,096	3,842	5,303	7,420	7,296	7,860	6,281	5,968
Net Income Numbers are in millions	10,067	20,338	20,022	19,715	19,205	19,139	18,023	15,863	19,094.619	13,466	12,448	12,307	12,176	11,726	9,335	9,249	8,853	8,504	8,297	7,474	6,730
Net Income Ratio Numbers are in millions	0.061	0.117	0.12	0.127	0.128	0.114	0.108	0.101	0.119	0.098	0.097	0.097	0.1	0.089	0.072	0.072	0.071	0.037	0.032	0.03	0.031
EPS Numbers are in millions	135.42	268.16	259.61	252.35	245.7	244.07	228.04	201.31	238.82	165.55	152.72	150.28	148.68	143.18	113.98	112.93	107.93	102.8	100.38	90.06	80.85
EPS Diluted Numbers are in millions	135.42	268.16	259.58	252.35	245.7	244.07	227.95	201.03	238.47	165.3	152.72	150.28	148.68	143.18	113.98	112.93	107.9	102.71	100.23	89.5	80.85
EBITDA Numbers are in millions	32,732	33,647	31,864	30,786	29,915	30,336	29,594	26,328	29,930.592	21,054	21,013	21,219	19,874	23,096	17,393	17,637	19,266	18,388	18,890	16,915	15,590
EBITDA Ratio Numbers are in millions	0.198	0.194	0.192	0.198	0.199	0.181	0.177	0.168	0.187	0.153	0.164	0.167	0.164	0.176	0.133	0.137	0.153	0.081	0.073	0.068	0.072

Kobayashi Pharmaceutical Co., Ltd.

TSE:4967.T Add to watchlist

TSE:4967.T